Val T. Hoyle bought Novo Nordisk A/S (NYSE: NVO)
Val T. Hoyle (D-OR), a U.S. Representative, has disclosed 1 trade in Novo Nordisk A/S (NVO) since 2024, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Val T. Hoyle bought $1,001 - $15,000 of Novo Nordisk A/S (NYSE: NVO) on October 29, 2024. Since that trade, NVO is down -50.93% against the S&P 500 up +27.64%, an outperformance of -78.57%.
Data updated
Val T. Hoyle's NVO trades vs the price
NVO is down -50.93% since Val T. Hoyle bought on October 29, 2024, versus +27.64% for the S&P 500.
Performance since this trade
All Val T. Hoyle NVO trades
Val T. Hoyle & NVO trading FAQ
Is it legal for Val T. Hoyle to trade Novo Nordisk A/S (NVO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novo Nordisk A/S (NVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Val T. Hoyle buy NVO?
Val T. Hoyle disclosed a purchase of $1,001 - $15,000 of Novo Nordisk A/S (NVO) on October 29, 2024, according to public STOCK Act filings.
How has NVO performed since Val T. Hoyle's trade?
Since Val T. Hoyle bought NVO on October 29, 2024, the stock is down -50.93%, versus +27.64% for the S&P 500 over the same period, an outperformance of -78.57%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVO trades?
Quantellect tracks every disclosed congressional trade in Novo Nordisk A/S (NVO) on the Novo Nordisk A/S congressional trading page, which aggregates filings across all members of Congress.
Val T. Hoyle's NVO tradesAll congressional filings for Novo Nordisk A/SVal T. Hoyle's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.